Related Experiment Videos
Ligand identification for G-protein-coupled receptors: a lead generation perspective
Konrad H Bleicher1, Luke G Green, Rainer E Martin
1F Hoffmann-La Roche Ltd, Pharmaceuticals Division, Lead Generation, PRBD-CI, Bldg 65/410, CH-4070 Basel, Switzerland. konrad.bleicher@roche.com
Current Opinion in Chemical Biology
|June 9, 2004
Summary
Discover novel G-protein-coupled receptor ligands beyond traditional screening. This review explores chemical intuition and in silico methods for innovative drug discovery, presenting supporting pharmacological data.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Pharmacology
Background:
- G-protein-coupled receptors (GPCRs) are crucial drug targets.
- Classical screening methods have limitations in identifying novel ligands.
- Exploring alternative strategies is essential for expanding GPCR ligand discovery.
Purpose of the Study:
- To review non-classical strategies for generating GPCR ligands.
- To highlight chemical intuition-based and in silico approaches.
- To provide examples with supporting pharmacological data.
Main Methods:
- Endogenous ligand elaboration
- Privileged structure decoration
- Virtual screening
- De novo design
Main Results:
- Demonstration of diverse strategies for GPCR ligand generation.
- Integration of chemical intuition and computational methods.
- Validation through cited pharmacological data.
Conclusions:
- Non-classical approaches offer powerful alternatives for GPCR ligand discovery.
- Combining chemical insight with computational tools enhances ligand generation.
- These strategies facilitate the development of novel therapeutics targeting GPCRs.